MB
Medsyn Biopharma LLC
SEC filingPharmaceuticals · Northville, MI
Amount raised$11.5Msold at filing
Total offering$11.5M$1 still open
Investors in the raise16count reported to the SEC
FiledNov 4, 2025first sale Oct 20, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Martin Mel MatthewExecutive Officer
Brian Mel WoodExecutive Officer
John Mel SorensenExecutive Officer, Director
Shaomeng Mel WangDirector
Executive officers, directors and promoters as listed on the Form D.